Home › Funds › OCCUDO QUANTITATIVE STRATEGIES LP › RPRX

OCCUDO QUANTITATIVE STRATEGIES LP position in RPRX

ROYALTY PHARMA PLC · Health Care

OCCUDO QUANTITATIVE STRATEGIES LP reported holding 165,177 shares of RPRX (ROYALTY PHARMA PLC) in its Q2 2026 13F filing — a position valued at US$9.3M, representing 0.49% of its reported portfolio and ranking #42 among its reported holdings. OCCUDO QUANTITATIVE STRATEGIES LP has disclosed RPRX holdings in 5 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)165.18K sh
Reported value held$9.26M
Portfolio Weight0.49%
First reportedQ3 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How OCCUDO QUANTITATIVE STRATEGIES LP's RPRX position evolved

OCCUDO QUANTITATIVE STRATEGIES LP first disclosed a stake in RPRX in Q3 2024 at 11,460 shares (US$324K). The position peaked in Q2 2026 at 165,177 shares, worth US$9.3M. Across 5 filings, OCCUDO QUANTITATIVE STRATEGIES LP increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 165,177 shares valued at US$9.3M — an increase of 43,377 shares quarter over quarter.. Notable position changes include a 96% increase in Q4 2024 (shares rose 22% over the following quarter), a 248% increase in Q1 2025 (shares rose 16% over the following quarter), a 36% increase in Q2 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 11.46K $324.20K New
Q4 2024 22.51K $574.28K Add
Q1 2025 78.38K $2.46M Add
Q1 2026 121.80K $6.10M New
Q2 2026 165.18K $9.26M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RPRX and 13F data

RPRX (ROYALTY PHARMA PLC) is a Health Care company. 50 other funds we track also report a position in RPRX — the largest reported positions include Swedbank AB (US$601.4M), Baillie Gifford & Co (US$561.6M), Caledonia (Private) Investments Pty Ltd (US$323.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RPRX

All RPRX fund holders →

FAQ

How long has OCCUDO QUANTITATIVE STRATEGIES LP held RPRX?

OCCUDO QUANTITATIVE STRATEGIES LP has disclosed RPRX holdings in 5 of the last 8 reported quarters, going back to Q3 2024.

What is OCCUDO QUANTITATIVE STRATEGIES LP's current position in RPRX?

As of Q2 2026, OCCUDO QUANTITATIVE STRATEGIES LP holds 165.18K shares of RPRX (ROYALTY PHARMA PLC), valued at $9.26M, representing 0.49% of its reported portfolio and ranking #42.

Has OCCUDO QUANTITATIVE STRATEGIES LP been buying or selling RPRX?

In the latest 13F filing (Q2 2026), OCCUDO QUANTITATIVE STRATEGIES LP increased its position in RPRX. The position peaked in Q2 2026 at 165.18K shares.

Which other funds hold RPRX?

Other major institutional holders of RPRX include Swedbank AB, Baillie Gifford & Co, Caledonia (Private) Investments Pty Ltd, among 50 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.